EE
Easom Eric disclosed a 6.2% stake in ANTX
Easom Eric reported owning 6.2% of AN2 Therapeutics, Inc. (ANTX) (2,409,486 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G